Upon ligand engagement, these receptors in turn engage MyD88 which signals through IRAK4 to turn on a variety of pathways, including NF-kB and the secretion of pro-inflammatory cytokines.
FORBES: Immunokinase Drug Candidates: $12B in Value Creation and Counting